Cargando…
Recurrent respiratory papillomatosis: the role of cidofovir
Recurrent respiratory papillomatosis (RRP) is a rare condition that affects the respiratory system. It is caused by human papilloma virus (HPV) infection. Usually infection and papilloma growth is limited to 6–12 months duration; however, some patients have persistent disease, resulting in long‐term...
Autores principales: | Tran, Mai Ngoc, Galt, Lauren, Bashirzadeh, Farzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167758/ https://www.ncbi.nlm.nih.gov/pubmed/30302253 http://dx.doi.org/10.1002/rcr2.371 |
Ejemplares similares
-
Efficacy of cidofovir in recurrent juvenile respiratory papillomatosis
por: Valera, Fabiana, et al.
Publicado: (2015) -
Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis
por: Broekema, Ferdinand I., et al.
Publicado: (2008) -
Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis
por: Wierzbicka, Małgorzata, et al.
Publicado: (2011) -
Recurrent respiratory papillomatosis by HPV: review
of the literature and update on the use of cidofovir
por: FUSCONI, M., et al.
Publicado: (2014) -
Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide(®))
por: Tjon Pian Gi, Robin E. A., et al.
Publicado: (2011)